Randomized, Open Label, Clinical Study of the Targeted Therapy, Palbociclib, to Treat Metastatic Breast Cancer

NCT02947685 · clinicaltrials.gov ↗

PHASE3

Phase

ACTIVE_NOT_RECRUITING

Status

518

Enrollment

OTHER

Sponsor class

Conditions

HER-2 Positive Breast Cancer
Estrogen Receptor Positive Breast Cancer

Interventions

DRUG: palbociclib
DRUG: trastuzumab
DRUG: pertuzumab
DRUG: letrozole
DRUG: Anastrozole
DRUG: Exemestane
DRUG: Fulvestrant

Sponsor

Alliance Foundation Trials, LLC.

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]